Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. C. Marchion
Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition
Cancer Research
Cancer Research
Oncology
Related publications
The Inhibition of Cellular Recovery in Human Tumour Cells by Inhibitors of Topoisomerase
British Journal of Cancer
Cancer Research
Oncology
Ciprofloxacin-Induced Inhibition of Topoisomerase II in Human Lymphoblastoid Cells.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Mechanism of Topoisomerase II Inhibition by Staurosporine and Other Protein Kinase Inhibitors
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells
PLoS ONE
Multidisciplinary
The Effect of CRM1 Inhibition on Human Non-Hodgkin Lymphoma Cells
Blood Cancer Journal
Oncology
Hematology
Simvastatin-Induced Compartmentalisation of Doxorubicin Sharpens Up Nuclear Topoisomerase II Inhibition in Human Rhabdomyosarcoma Cells
Naunyn-Schmiedeberg's Archives of Pharmacology
Medicine
Pharmacology
The Mechanisms of Sensitization of Gastrointestinal Stromal Tumor Cells to DNA Topoisomerase II Inhibitors
Kazan medical journal
Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs
International Journal of Molecular Medicine
Medicine
Genetics
Proteasome Inhibitors Block Ikaros Degradation by Lenalidomide in Multiple Myeloma
Haematologica
Hematology